Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

[Beijing China (Mainland) ]

  • 1st
Business Type:
Manufacturer
Year Established:
2006
Total Revenue:
US$10 Million - US$50 Million
Main Products:
Lamivudine, Emtricitabine, Nevirapine, Ritonavir, CME, HME, API and Intermediates of<br /> Anti-Viral, FCME

Product Showcase

  • Lamivudine
  • GMP certified Lamivudine
  • Emtricitabine
  • Nevirapine
  • Lopinavir
  • Ritonavir
View All Products

Contacts

Ms. Emma Li
Start Order